TRIAMTERENE - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for triamterene and what is the scope of freedom to operate?

Triamterene is the generic ingredient in two branded drugs marketed by Concordia, Agnitio, and Hibrow Hlthcare, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for triamterene. Four suppliers are listed for this compound.

Summary for TRIAMTERENE

US Patents:	0
Tradenames:	2
Applicants:	3
NDAs:	3
Drug Master File Entries:	17
Finished Product Suppliers / Packagers:	4
Raw Ingredient (Bulk) Api Vendors:	130
Clinical Trials:	8
Patent Applications:	6,466
Drug Prices:	Drug price trends for TRIAMTERENE
Drug Sales Revenues:	Drug sales revenues for TRIAMTERENE
What excipients (inactive ingredients) are in TRIAMTERENE?	TRIAMTERENE excipients list
DailyMed Link:	TRIAMTERENE at DailyMed

See drug prices for TRIAMTERENE

Recent Clinical Trials for TRIAMTERENE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of California, Irvine	Phase 4
Vanderbilt University	Phase 4
West China Hospital	Phase 4

See all TRIAMTERENE clinical trials

Pharmacology for TRIAMTERENE

Drug Class	Potassium-sparing Diuretic
Physiological Effect	Decreased Renal K+ Excretion Increased Diuresis

Medical Subject Heading (MeSH) Categories for TRIAMTERENE

Diuretics
Epithelial Sodium Channel Blockers

Anatomical Therapeutic Chemical (ATC) Classes for TRIAMTERENE

C03DB	Other potassium-sparing agents
C03D	ALDOSTERONE ANTAGONISTS AND OTHER POTASSIUM-SPARING AGENTS
C03	DIURETICS
C	Cardiovascular system

US Patents and Regulatory Information for TRIAMTERENE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Agnitio	TRIAMTERENE	triamterene	CAPSULE;ORAL	211581-002	Aug 19, 2019	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Hibrow Hlthcare	TRIAMTERENE	triamterene	CAPSULE;ORAL	214768-002	Jul 6, 2022		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Concordia	DYRENIUM	triamterene	CAPSULE;ORAL	013174-002	Approved Prior to Jan 1, 1982	AB	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.